Stock News and Filings Feed


Add OSCAR
to your dashboard

Supreme Court asks Singh brothers to maintain status quo on Fortis Healthcare stake

2017-08-11 livemint
New Delhi: The Supreme Court on Friday directed former Ranbaxy promoters, Malvinder and Shivender Singh, to maintain status quo with regard to their stake in Fortis Healthcare Ltd.

RHC Holding’s NCDs downgraded as Singh brothers default on payment

2017-07-16 livemint
India Ratings has downgraded NCDs of RHC Holding at a time when Singh brothers are in talks with banks to meet repayment obligations of Religare Enterprises

Delhi HC seeks Fortis reply to Daiichi’s contempt plea by 10 August

2017-07-05 livemint
Fortis Healthcare Holdings has been selling its unencumbered assets without applying to the court, says Daiichi Sankyo

Daiichi contempt plea: Delhi HC tells Fortis promoters to respond by Aug 10

2017-07-05 business-standard
The Delhi High Court on Tuesday asked RHC Holdings and Oscar Investments (companies owned by former Ranbaxy promoters Malvinder and Shivinder Singh) to respond by August 10 to a contempt application filed against them by Japanese pharmaceutical major Daiichi Sankyo.

Daiichi case: Delhi HC allows Fortis stake sale by Singh brothers with rider

2017-06-21 livemint
The order to allow conditional stake sale by Singh brothers in Fortis Healthcare was passed to afford protection to Daiichi Sankyo in terms of ready realizable value of assets at a later stage

IHH Healthcare set to seal deal for Fortis, SRL stake

2017-06-19 livemint
IHH Healthcare to buy 26% stake in Fortis from Malvinder and Shivinder Singh; both sides agree to a combined $2.9 billion valuation for Fortis and SRL Diagnostics

Board of Oscar Investments approves change in MD

2017-05-03 indiainfoline
Disclaimer: The contents herein is specifically prepared by ‘Dalal Street Investment Journal’, and is for your information & personal consumption only. India Infoline Limited or Dalal Street Investment Journal do not guarantee the accuracy, correctness, completeness or reliability of information contained herein and shall not be held responsible.

Daiichi protests Singhs' Religare Health Insurance stake sale in court

2017-04-17 business-standard
Daiichi Sankyo approached the Delhi High Court on Monday to protest against the 80 percent stake sale of Religare Health Insurance by former Ranbaxy promoter's Malvinder and Shivinder Singh. The objection to the April 9 sale of Religare's insurance business with private equity fund True North Managers marks Daiichi's latest attempt at securing the assets of the Singh brothers for the realisation of a Rs 2,562 crore Singapore arbitration award in favour of the Japanese pharmaceutical major.

Shivinder and Malvinder Singh look to sell some assets, but there’s a catch

2017-03-28 livemint
The latest turn in a long running legal brawl with Daiichi Sankyo means Shivinder Singh and Malvinder Singh can’t change the status of their holdings without first getting permission from the Delhi high court

Indian tycoons known for lucky timing find time in short supply

2017-03-28 theedgemarkets
MUMBAI (March 28): India’s Singh brothers are serial entrepreneurs known for pulling off one of the best-timed exits in the annals of Indian business.

7
shares
Indian Tycoons Known for Lucky Timing Find Time In Short Supply - Bloomberg

2017-03-28 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

2
shares
Daiichi claims former Ranbaxy promoters made false declaration in Delhi HC

2017-03-20 business-standard
Daiichi Sankyo made its fourth attempt in the Delhi High Court on Monday to secure the assets of Malvinder Singh and Shivinder Singh (and their affiliate companies), after claiming that the former Ranbaxy promoters had made false statements in earlier affidavits tendered before the court. The affidavits in question had been submitted by the Singh brothers in line with directions issued on a petition seeking the enforcement of a Rs 2,562 crore Singapore arbitral award in favour of the Japanese pharma major.

19
shares
Ranbaxy's Singh brothers told to pay Rs 2,562 crore fine to Daiichi

2016-05-06 business-standard
An arbitration court in Singapore has ordered Malvinder Singh and Shivinder Mohan Singh, former owners of Ranbaxy Laboratories, to pay damages worth Rs 2,562.78 crore (based on Thursday's exchange rate) to Japan's Daiichi Sankyo Co. Malvinder Singh, currently chairman of Fortis Healthcare, and his brother Shivinder Singh will have to pay the fine for concealing and misrepresenting facts from the Japanese drug giant when it purchased about 35 per cent stake in Ranbaxy from them in 2008.

Ranbaxy sale: Malvinder, Shivinder Singh told to pay Rs 2,563 crore fine

2016-05-06 financialexpress
Former promoters of Ranbaxy Laboratories Malvinder and Shivinder Mohan Singh have suffered a big jolt with a Singapore arbitration tribunal asking them to pay damages of Rs 2,562.78 crore to Daiichi Sankyo for concealing and misrepresenting information during the sale of their stake in 2008 to the Japanese firm.

Singh brothers told to pay Rs 2,562-crore fine to Daiichi

2016-05-05 business-standard
An arbitration court in Singapore has ordered Malvinder Singh and Shivinder Mohan Singh, former owners of Ranbaxy Laboratories, to pay damages worth Rs 2,562.78 crore (based on Thursday's exchange rate) to Japan's Daiichi Sankyo Co. Malvinder Singh, currently chairman of Fortis Healthcare, and his brother Shivinder Singh will have to pay the fine for concealing and misrepresenting facts from the Japanese drug giant when it purchased about 35 per cent stake in Ranbaxy from them in 2008.

Malvinder & Shivinder Singh asked to pay damages of Rs 2,500 crore in Daiichi-Ranbaxy case

2016-05-05 financialexpress
Malvinder & Shivinder Singh and their family, the erstwhile promoters of Ranbaxy Laboratories, have been asked to pay damages of Rs 2,562.78 crore to Daiichi by a Singapore arbitration tribunal for concealing and misrepresenting information during their stake sell to the Japanese firm.

Pay Rs 2,500 cr to Daiichi for hiding facts, court tells ex-Ranbaxy promoters Malvinder & Shivinder Mohan Singh

2016-05-05 business-standard
The erstwhile promoters of Ranbaxy Laboratories, the Singh brothers and family have been asked to pay damages of Rs 2,562.78 crore to Daiichi by an arbitration tribunal here for concealing and misrepresenting information during their stake sell to the Japanese firm. Malvinder Singh, currently the Chairman of Fortis Healthcare, and family including his brother Shivinder Singh, had sold their entire stake of about 35 per cent in Ranbaxy for $2.

Fintel IR - Find the Right Investors for Your Company, Instantly!

Fintel IR combines the comprehensive Fintel ownership database with machine learning to provide advanced tools to make investor outreach fast and easy. Learn more now!